Mwanzo539523 • BOM
add
Alkem Laboratories Ltd
Bei iliyotangulia
₹ 4,723.95
Bei za siku
₹ 4,609.50 - ₹ 4,752.90
Bei za mwaka
₹ 4,409.90 - ₹ 6,440.00
Thamani ya kampuni katika soko
553.45B INR
Wastani wa hisa zilizouzwa
elfu 3.59
Uwiano wa bei na mapato
25.73
Mgao wa faida
0.91%
Ubadilishanaji wa msingi
NSE
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(INR) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato | 33.74B | 1.52% |
Matumizi ya uendeshaji wa biashara | 14.96B | 8.29% |
Mapato halisi | 6.26B | 5.19% |
Kiwango cha faida halisi | 18.55 | 3.63% |
Mapato kwa kila hisa | 52.34 | -2.59% |
EBITDA | 7.39B | 4.74% |
Asilimia ya kodi ya mapato | 12.35% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
(INR) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 22.89B | -36.59% |
Jumla ya mali | — | — |
Jumla ya dhima | — | — |
Jumla ya hisa | 119.10B | — |
hisa zilizosalia | 119.57M | — |
Uwiano wa bei na thamani | 4.91 | — |
Faida inayotokana na mali | — | — |
Faida inayotokana mtaji | 12.59% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
(INR) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato halisi | 6.26B | 5.19% |
Pesa kutokana na shughuli | — | — |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | — | — |
Mabadiliko halisi ya pesa taslimu | — | — |
Mtiririko huru wa pesa | — | — |
Kuhusu
Alkem Laboratories Limited is a leading Indian multinational pharmaceutical company headquartered in Mumbai, India. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets a diverse portfolio of pharmaceutical generics, formulations and nutraceuticals across India and global markets.
With over five decades of expertise in the pharmaceutical industry, Alkem's journey began with a vision to transform India's healthcare landscape. Today, the company has established its presence in over 40 countries, operating 19 state-of-the-art manufacturing facilities and driving innovation through a team of 500+ scientists. Backed by a robust portfolio of 800+ brands, Alkem continues to set industry benchmarks in research, development, and manufacturing excellence.
Alkem primarily focuses on developing medications for a wide range of therapeutic areas, including infectious diseases, gastrointestinal disorders, pain management, gynecological conditions, pediatrics, osteoporosis, arthritis, cardiovascular diseases, diabetes, and several other critical health concerns. Wikipedia
Ilianzishwa
1973
Makao Makuu
Tovuti
Wafanyakazi
17,432